insight engineers
A market research and consultancy company working for blue-chip clients in the Automotive, Energy, Retail, Healthcare and Service sectors
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Graphite Digital
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
Havas Life London
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
Healthcare Research Worldwide
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Onyx Health
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins – The Patient Focused Specialists
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Visions4Health
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation
Press Releases | September 17, 2025 | Innovative Trials
Kate Shaw comments on the latest news about AstraZeneca and Merck's decision to hold planned investments in the UK
Lucid Strategy Consulting: Empowering Next-Generation Solutions for Life Sciences
Press Releases | September 16, 2025 | Lucid Group Communications Limited
Lucid Group announces the evolution of its consulting division, Lucid Strategy Consulting, setting a new standard for deep-domain, knowledge-led consulting solutions for life sciences. We have brought together two Lucid...
Streamlining European expansion for cell and gene therapies
White Papers and Resources | September 16, 2025 | Uniphar
Tom Smith, Strategic Director, Cell and Gene Therapies, Uniphar, discusses the essential elements biotechs need for commercial success in Europe’s unique market when developing cell and gene therapies (CGTs). Europe...
Current CGT landscape and future outlook
White Papers and Resources | September 16, 2025 | Uniphar
What makes CGT unique Cell and gene therapy (CGT) is a unique treatment that uses cells and genetic material to treat and cure diseases. Personalized to the patient, CGT’s offer...
Building for Success: Aligning Preclinical and Phase 1 Strategy with Commercial Goals
White Papers and Resources | September 16, 2025 | Uniphar
This article concludes our three-part series on preparing cell and gene therapies (CGTs) for successful launch and long-term viability. The first article explored the unique scientific and logistical challenges of...
Navigating the complexities of launch preparation for Cell and Gene Therapy
White Papers and Resources | September 16, 2025 | Uniphar
Cell and gene therapies (CGT) provide transformative treatment that can treat conditions that were previously considered untreatable. As described in the previous article in this series, most CGTs target patients...
Virtual Practice, Real Results: The Power of Virtual Patient Simulation
Press Releases | September 15, 2025 | Medscape Education
Simulation has never been more vital in medicine than it is today. As increasing numbers of physicians turn to large language models for clinical answers1, the real differentiator isn’t just...
A New Destination for Oncology Education
Press Releases | September 15, 2025 | Medscape Education
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce...
A Call to Action: Bridging the Adult Immunization Divide
Press Releases | September 12, 2025 | Medscape Education
Over the past few years, as new diseases have emerged or reemerged, a host of new vaccines have become available while many others are in the pipeline. For older adults,...
ISPOR hosts expert webinar exploring the value of ECAs for regulatory and HTA evidence needs
Press Releases | September 12, 2025 | Genesis Research Group
On Tuesday, October 7th, you are invited to join a Genesis Research Group-led webinar exploring the value of External Control Arm (ECA) studies. Gaining traction as part of evidence generation...